JP2018534595A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018534595A5 JP2018534595A5 JP2018543010A JP2018543010A JP2018534595A5 JP 2018534595 A5 JP2018534595 A5 JP 2018534595A5 JP 2018543010 A JP2018543010 A JP 2018543010A JP 2018543010 A JP2018543010 A JP 2018543010A JP 2018534595 A5 JP2018534595 A5 JP 2018534595A5
- Authority
- JP
- Japan
- Prior art keywords
- configuration
- genomic
- gene
- cnv
- configurations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562250422P | 2015-11-03 | 2015-11-03 | |
| US62/250,422 | 2015-11-03 | ||
| PCT/US2016/059877 WO2017079139A1 (en) | 2015-11-03 | 2016-11-01 | Single cell genomic profiling of circulating tumor cells (ctcs) in metastatic disease to characterize disease heterogeneity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018534595A JP2018534595A (ja) | 2018-11-22 |
| JP2018534595A5 true JP2018534595A5 (https=) | 2019-11-28 |
| JP7043412B2 JP7043412B2 (ja) | 2022-03-29 |
Family
ID=58662599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018543010A Active JP7043412B2 (ja) | 2015-11-03 | 2016-11-01 | 疾患の不均一性を特徴づけるための転移性疾患における、循環腫瘍細胞（ｃｔｃ）の単一細胞ゲノムプロファイリング |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20180321247A1 (https=) |
| EP (1) | EP3371327B1 (https=) |
| JP (1) | JP7043412B2 (https=) |
| CN (2) | CN115341033A (https=) |
| AU (2) | AU2016348401A1 (https=) |
| CA (1) | CA3004150A1 (https=) |
| EA (1) | EA201891085A1 (https=) |
| IL (1) | IL259093A (https=) |
| WO (1) | WO2017079139A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011050103A1 (en) | 2009-10-21 | 2011-04-28 | The Scripps Research Institute | Method of using non-rare cells to detect rare cells |
| US10527624B2 (en) | 2014-01-27 | 2020-01-07 | Epic Sciences, Inc. | Circulating tumor cell diagnostics for prostate cancer biomarkers |
| EP3108246B1 (en) | 2014-02-21 | 2019-10-09 | Epic Sciences, Inc. | Methods for analyzing rare circulating cells |
| AU2020245775B2 (en) * | 2019-03-28 | 2025-07-10 | Lundoch Diagnostics AB | Use of follistatin in type 2 diabetes risk prediction |
| US12412272B2 (en) | 2019-11-26 | 2025-09-09 | University Of Cincinnati | Characterizing intra-site tumor heterogeneity |
| CN117497044A (zh) * | 2022-03-09 | 2024-02-02 | 复旦大学 | 基于单细胞基因组拷贝数变异谱在制造细胞良恶性诊断试剂或检测试剂中的应用 |
| WO2024192141A1 (en) | 2023-03-13 | 2024-09-19 | Dana-Farber Cancer Institute, Inc. | Treatment of cancers having a drug-resistant mesenchymal cell state |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014047285A1 (en) * | 2012-09-19 | 2014-03-27 | Paraskevi Giannakakou | Identifying taxane sensitivity in prostate cancer patients |
| AU2014248007B2 (en) | 2013-04-05 | 2020-03-26 | Myriad Genetics, Inc. | Methods and materials for assessing homologous recombination deficiency |
| WO2015048740A1 (en) * | 2013-09-30 | 2015-04-02 | The Scripps Research Institute | Genotypic and phenotypic analysis of circulating tumor cells to monitor tumor evolution in prostate cancer patients |
| US20150147339A1 (en) * | 2013-11-15 | 2015-05-28 | Psma Development Company, Llc | Biomarkers for psma targeted therapy for prostate cancer |
| CA2937051A1 (en) * | 2014-01-17 | 2015-07-23 | Ontario Institute For Cancer Research (Oicr) | Biopsy-driven genomic signature for prostate cancer prognosis |
| US10527624B2 (en) * | 2014-01-27 | 2020-01-07 | Epic Sciences, Inc. | Circulating tumor cell diagnostics for prostate cancer biomarkers |
| US20150212089A1 (en) * | 2014-01-30 | 2015-07-30 | Epic Sciences, Inc. | Circulating tumor cell diagnostics for biomarkers predictive of resistance to androgen receptor (ar) targeted therapies |
-
2016
- 2016-11-01 EP EP16862785.9A patent/EP3371327B1/en active Active
- 2016-11-01 US US15/773,154 patent/US20180321247A1/en not_active Abandoned
- 2016-11-01 CN CN202210906018.2A patent/CN115341033A/zh active Pending
- 2016-11-01 WO PCT/US2016/059877 patent/WO2017079139A1/en not_active Ceased
- 2016-11-01 CN CN201680078293.2A patent/CN108603233A/zh active Pending
- 2016-11-01 AU AU2016348401A patent/AU2016348401A1/en not_active Abandoned
- 2016-11-01 JP JP2018543010A patent/JP7043412B2/ja active Active
- 2016-11-01 CA CA3004150A patent/CA3004150A1/en active Pending
- 2016-11-01 EA EA201891085A patent/EA201891085A1/ru unknown
-
2018
- 2018-05-02 IL IL259093A patent/IL259093A/en unknown
-
2021
- 2021-01-06 US US17/142,767 patent/US20210405055A1/en not_active Abandoned
-
2023
- 2023-01-24 AU AU2023200364A patent/AU2023200364A1/en not_active Abandoned
-
2024
- 2024-07-11 US US18/770,366 patent/US20250180564A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018534595A5 (https=) | ||
| JP2019502384A5 (https=) | ||
| Desitter et al. | A new device for rapid isolation by size and characterization of rare circulating tumor cells | |
| Pantel et al. | Liquid biopsy and minimal residual disease—latest advances and implications for cure | |
| Laget et al. | Technical insights into highly sensitive isolation and molecular characterization of fixed and live circulating tumor cells for early detection of tumor invasion | |
| Durinikova et al. | Preclinical models as patients’ avatars for precision medicine in colorectal cancer: past and future challenges | |
| Xu et al. | Organoid technology and applications in cancer research | |
| Jain et al. | Molecular pathology of lung cancer cytology specimens: a concise review | |
| Chang et al. | DACH1 stimulates shear stress-guided endothelial cell migration and coronary artery growth through the CXCL12–CXCR4 signaling axis | |
| Lohmussaar et al. | Human-derived model systems in gynecological cancer research | |
| Blassl et al. | Gene expression profiling of single circulating tumor cells in ovarian cancer–Establishment of a multi-marker gene panel | |
| Chen et al. | Human solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus | |
| Li et al. | Molecular characterization of circulating tumor cells—from bench to bedside | |
| Schmid-Bindert et al. | EBUS-TBNA provides highest RNA yield for multiple biomarker testing from routinely obtained small biopsies in non-small cell lung cancer patients-a comparative study of three different minimal invasive sampling methods | |
| EP4484572A3 (en) | Identification and use of circulating nucleic acid tumor markers | |
| Premasekharan et al. | An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer | |
| Venkataraman et al. | Current status of prognostication in classical Hodgkin lymphoma | |
| JP2016516091A5 (https=) | ||
| CN106244553A (zh) | 循环肿瘤细胞的分离和检测方法 | |
| Regauer et al. | Cervical precancers originate from infected proliferating reserve cells: a comparative histologic and genetic study of thin and thick high-grade squamous intraepithelial lesions | |
| Bünger et al. | Diversity of assessing circulating tumor cells (CTCs) emphasizes need for standardization: a CTC Guide to design and report trials | |
| EA201891085A1 (ru) | Получение геномных профилей отдельных клеток для циркулирующих клеток опухолей (ctc) при метастазирующем заболевании для характеризации гетерогенности заболевания | |
| Wood et al. | Neuromesodermal progenitors separate the axial stem zones while producing few single-and dual-fated descendants | |
| JP2018536175A5 (https=) | ||
| CN104404034A (zh) | 利用口腔上皮细胞制作单细胞测序参考品的方法 |